Connect Biopharma Holdings Limited announced Mr. Jiang Bian has joined the Company as General Counsel & Chief Compliance Officer, effective August 20, 2021. In his role, Mr. Bian will oversee Connect Biopharma’s legal function and will report to Dr. Zheng Wei, Co-founder and CEO. The hiring of Mr. Bian is an important step in filling out the Company’s Executive Leadership and advancing the organizational growth strategy. Separately, the Company announced a change to the composition of its Board of Directors, with the appointment of Jean Liu, J.D., Executive Vice President, Legal Affairs, General Counsel and Secretary of Seagen Inc., a targeted cancer therapeutic company. Ms. Liu joins as an Independent Director to the Company. Mr. Bian joins Connect Biopharma from Guardant Health Inc., a publicly traded precision oncology diagnostics company, based in Redwood City, California, where he served as Senior Counsel. Prior to Guardant Health, Mr. Bian was with Shartsis Friese LLP where he focused on corporate and technology licensing areas of legal advisory. Mr. Bian also held positions of increasing responsibility, including Senior Counsel at Pieris Pharmaceuticals Inc., a publicly traded biotechnology company.